Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing

Understanding genetic aberrations in cancer leads to discovery of new targets for cancer therapies. The genomic landscape of hepatocellular carcinoma (HCC) has not been fully described. Therefore, patients with refractory advanced/metastatic HCC referred for experimental therapies, who had adequate...

Descripción completa

Detalles Bibliográficos
Autores principales: Janku, Filip, Kaseb, Ahmed O., Tsimberidou, Apostolia M., Wolff, Robert A., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102787/
https://www.ncbi.nlm.nih.gov/pubmed/24931142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102787/
https://www.ncbi.nlm.nih.gov/pubmed/24931142

Ejemplares similares